SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway

BACKGROUND: The poor prognosis of patients with ovarian cancer is mainly due to cancer progression. γ-Synuclein (SNCG) has reported as a critical player in cancer metastasis. However, its biological roles and mechanism are yet incompletely understood in ovarian cancer, especially in high-grade serou...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Liu, Xiao-han, Li, Cong, Wu, Xiao-xing, Chen, Yan-lin, Li, Wen-wen, Li, Xian, Gong, Fan, Tang, Qin, Jiang, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204046/
https://www.ncbi.nlm.nih.gov/pubmed/32381034
http://dx.doi.org/10.1186/s13046-020-01589-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204046/
https://www.ncbi.nlm.nih.gov/pubmed/32381034
http://dx.doi.org/10.1186/s13046-020-01589-9

Ejemplares similares